Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents. [electronic resource]
Producer: 20100809Description: 391-6 p. digitalISSN:- 1532-0987
- Adolescent
- Animals
- Antibodies, Bacterial -- blood
- Child
- Diphtheria Toxoid -- adverse effects
- Female
- HIV Infections -- immunology
- Humans
- Male
- Meningococcal Infections -- prevention & control
- Meningococcal Vaccines -- adverse effects
- Microbial Viability -- immunology
- Neisseria meningitidis, Serogroup A -- immunology
- Neisseria meningitidis, Serogroup C -- immunology
- Neisseria meningitidis, Serogroup W-135 -- immunology
- Neisseria meningitidis, Serogroup Y -- immunology
- Surveys and Questionnaires
- United States
- Vaccines, Conjugate
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.